# Relates to newborn screening for glucose-6-phosphate dehydrogenase deficiency

**Bill ID:** A7338
**Session:** 2023
**Sponsor:** Amy Paulin
**Status:** Assembly Floor Calendar

## Summary

Removes limitations on newborn screening for glucose-6-phosphate dehydrogenase deficiency.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  7338
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  May 17, 2023
  ___________
 
 Introduced by M. of A. PAULIN -- read once and referred to the Committee
  on Health
 
 AN  ACT to amend the public health law, in relation to newborn screening
  for glucose-6-phosphate dehydrogenase deficiency
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

  Section  1.  Paragraph  (j)  of subdivision 1 of section 2500-a of the
 public health law, as amended by chapter 70 of  the  laws  of  2022,  is
 amended to read as follows:
  (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative
 enzymatic  test  or  other  diagnostic  test in cases where: the newborn
 infant presents with hemolytic anemia, hemolytic jaundice, or  early-on-
 set  increasing  neonatal  jaundice,  that is, jaundice (bilirubin level
 greater than fortieth percentile for age in hours) persisting beyond the
 day of birth through the week after birth; the newborn infant  has  been
 admitted to the hospital for jaundice following birth; or the biological
 parent  of the newborn infant indicates a family, racial, or ethnic risk
 of  glucose-6-phosphate  dehydrogenase  deficiency,  including  having
 significant African, Asian, Mediterranean, or Middle Eastern ancestry].
  ยง 2. This act shall take effect immediately.
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD10869-02-3